These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15215080)

  • 1. Defined anaerobic growth medium for studying Candida albicans basic biology and resistance to eight antifungal drugs.
    Dumitru R; Hornby JM; Nickerson KW
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2350-4. PubMed ID: 15215080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possible molecular mechanisms of farnesol on the antifungal resistance of C. albicans biofilms: the regulation of CYR1 and PDE2.
    Chen S; Xia J; Li C; Zuo L; Wei X
    BMC Microbiol; 2018 Dec; 18(1):203. PubMed ID: 30509171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.
    MacPherson S; Akache B; Weber S; De Deken X; Raymond M; Turcotte B
    Antimicrob Agents Chemother; 2005 May; 49(5):1745-52. PubMed ID: 15855491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tyrosol and farnesol on Candida albicans biofilm.
    Sebaa S; Boucherit-Otmani Z; Courtois P
    Mol Med Rep; 2019 Apr; 19(4):3201-3209. PubMed ID: 30816484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for cell density in antifungal drug resistance in Candida albicans biofilms.
    Perumal P; Mekala S; Chaffin WL
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2454-63. PubMed ID: 17502416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.
    De Brucker K; De Cremer K; Cammue BP; Thevissen K
    Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro method to study antifungal perfusion in Candida biofilms.
    Samaranayake YH; Ye J; Yau JY; Cheung BP; Samaranayake LP
    J Clin Microbiol; 2005 Feb; 43(2):818-25. PubMed ID: 15695686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal drug susceptibility of oral Candida albicans isolates may be associated with apoptotic responses to Amphotericin B.
    Yang C; Gong W; Lu J; Zhu X; Qi Q
    J Oral Pathol Med; 2010 Feb; 39(2):182-7. PubMed ID: 19656268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesol-mediated inhibition of Candida albicans yeast growth and rescue by a diacylglycerol analogue.
    Uppuluri P; Mekala S; Chaffin WL
    Yeast; 2007 Aug; 24(8):681-93. PubMed ID: 17583896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol.
    Hornby JM; Jensen EC; Lisec AD; Tasto JJ; Jahnke B; Shoemaker R; Dussault P; Nickerson KW
    Appl Environ Microbiol; 2001 Jul; 67(7):2982-92. PubMed ID: 11425711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal activity of a prenylated flavonoid from Dalea elegans against Candida albicans biofilms.
    Peralta MA; da Silva MA; Ortega MG; Cabrera JL; Paraje MG
    Phytomedicine; 2015 Oct; 22(11):975-80. PubMed ID: 26407939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases.
    Tobudic S; Lassnigg A; Kratzer C; Graninger W; Presterl E
    Mycoses; 2010 May; 53(3):208-14. PubMed ID: 19298353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans.
    Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H
    FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates.
    Shirazi F; Kontoyiannis DP
    Virulence; 2015; 6(4):385-94. PubMed ID: 26065323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biofilm formation by and antifungal susceptibility of Candida isolates from urine.
    Jain N; Kohli R; Cook E; Gialanella P; Chang T; Fries BC
    Appl Environ Microbiol; 2007 Mar; 73(6):1697-703. PubMed ID: 17261524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced production of farnesol by Candida albicans treated with four azoles.
    Hornby JM; Nickerson KW
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2305-7. PubMed ID: 15155241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes.
    Khot PD; Suci PA; Miller RL; Nelson RD; Tyler BJ
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3708-16. PubMed ID: 16966398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.